Incannex Historical Cash Flow
IXHL Stock | USD 1.78 0.04 2.20% |
Analysis of Incannex Healthcare cash flow over time is an excellent tool to project Incannex Healthcare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 2.9 M or Capital Expenditures of 256.7 K as it is a great indicator of Incannex Healthcare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Incannex Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Incannex Healthcare is a good buy for the upcoming year.
Incannex |
About Incannex Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Incannex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Incannex's non-liquid assets can be easily converted into cash.
Incannex Healthcare Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Incannex Healthcare to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Incannex Healthcare operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Incannex Healthcare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Incannex Healthcare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At this time, Incannex Healthcare's Begin Period Cash Flow is quite stable compared to the past year. Change To Liabilities is expected to rise to about 1.9 M this year, although the value of Free Cash Flow is projected to rise to (15.3 M).
2022 | 2023 | 2024 (projected) | Other Non Cash Items | 36.5M | 3.1M | 2.9M | Depreciation | 88K | 103K | 68.9K |
Incannex Healthcare cash flow statement Correlations
Click cells to compare fundamentals
Incannex Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Incannex Healthcare cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 2.4M | 4.4M | 19.0M | (3.8M) | (16.3M) | (15.4M) | |
Free Cash Flow | (3.9M) | (5.2M) | (8.8M) | (11.1M) | (16.1M) | (15.3M) | |
Begin Period Cash Flow | 64.1K | 2.5M | 6.8M | 25.9M | 22.1M | 23.2M | |
Other Cashflows From Financing Activities | (0.2) | 9.3M | 28.4M | 8.2M | (277K) | (263.2K) | |
Other Non Cash Items | 598.0K | 2.7M | 356.7K | 36.5M | 3.1M | 2.9M | |
Total Cash From Operating Activities | (3.9M) | (5.2M) | (8.8M) | (10.7M) | (15.8M) | (15.1M) | |
Net Income | (4.7M) | (8.5M) | (10.3M) | (48.8M) | (18.5M) | (17.5M) | |
Total Cash From Financing Activities | 2.0M | 5.1M | 9.3M | 28.4M | 8.2M | 0.0 | |
End Period Cash Flow | 2.5M | 6.8M | 25.9M | 22.1M | 5.9M | 4.5M | |
Investments | 13K | 29.3K | 0.0 | (476.9K) | (277K) | (263.2K) | |
Total Cashflows From Investing Activities | (24.4K) | 13K | 29.3K | (476.9K) | (429.2K) | (407.7K) | |
Change To Account Receivables | (315.5K) | 161.1K | (63.7K) | 7.2K | (9.8M) | (9.3M) | |
Change To Operating Activities | (27.3K) | (101.0K) | 207.6K | (848.0K) | (763.2K) | (725.0K) | |
Change To Netincome | 699.2K | 4.5M | 870.2K | 3.2M | 3.7M | 1.8M | |
Change To Liabilities | 464.2K | (291.3K) | 1.1M | 1.6M | 1.8M | 1.9M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.296 | Return On Assets (0.57) | Return On Equity (1.15) |
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.